SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics, (Nasdaq:MBRX), a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of metabolic and liver diseases by targeting the liver and liver pathways, announced today that it will now host its conference call and live webcast on Friday, August 3, 2007 at 8:30 a.m. Eastern Time to discuss its financial results for the second quarter of 2007. Dr. Paul Laikind, president and chief executive officer and Mr. John Beck, senior vice president of finance and chief financial officer, will participate in the call.
